In this interview they explain to us the new Monocyte treatment that they have added to those they were already carrying out until now; ozone treatment, platelet-rich plasma (PRP) and neural treatments, among others.
What are Monocytes?
Monocytes are cells with powerful anti-inflammatory properties and great regenerative capacity for tissues damaged by osteoarthritis or trauma, as well as chronic tendinopathies that do not improve with more conventional treatments such as physiotherapy.
Where are Monocytes found?
These cells belong to what we call the “white series” of the blood of all of us. They represent 10% of our total peripheral blood. It is shown that, in large destructive and inflammatory lesions, the Monocyte is mainly responsible for the regeneration of damaged tissues. This is precisely the property that we use of the Monocyte in the field of joint pain and wear that gives us such good results.
Who is Monocyte treatment mainly intended for?
Basically, any patient with pain whose cause is an injury to their own tissues.
Some examples:
• Osteoarthritis
• Tendinitis
• Fractures that do not heal
• Sports injuries
• Joint pain
• Ligament injuries
It is true that the majority of patients we treat are those who have been given surgery as the only alternative. With the Monocyte we have managed to avoid surgical intervention for a large number of them.
We are also treating many young people with sports and degenerative injuries with very good results. They have managed to return to their previous performance.
What is a treatment with Monocytes like?
We select Monocyte cells from blood taken from the patient (as an analysis). Subsequently, we filter this blood sample in a sophisticated mechanism that allows us to obtain the optimal Monocyte composition to infiltrate the damaged joint/tissue.
This new therapy, of which we are proud to be able to show our numerous successes obtained in the last year, allows us to provide our patients with the latest innovation that biological medicine offers us in the field of tissue regeneration.
What differentiates the treatment with Monocytes from other treatments such as PRP that were already being done in the Pain Unit?
The main difference is that PRP is an infiltration that focuses on the state of the injury to be treated.
PRP stimulates the chondrocyte (main cartilage cell) to multiply and repair the injury. The patient must have a sufficient number of chondrocytes to be stimulated.
The Monocyte, being a living cell, has the ability to generate chondrocytes in those lesions that lack it. This
difference allows us to treat more severe injuries that until today only had surgical intervention as an alternative.
Is it necessary to enter the operating room for this treatment?
Monocyte therapy is included in those treatments that are known as outpatient therapies.
They are carried out in aseptic areas and with all security measures. This is such a minimally invasive therapy that it cannot be considered surgical treatment.
The advantages this brings to patients are enormous. It does not depend on the previous pathologies that the patient has had. Nor about the pharmacological treatments that are being followed for other pathologies to which the treated patient is subjected.
Why avoid surgical intervention?
The alternative of replacing the joint itself with an artificial prosthesis should always be the last resort. Not only because it is an aggressive treatment, not absent of adverse effects, but
because when you opt for surgery you can no longer go back, giving up the fact that your body is capable of regenerating itself.
What is the future of Monocytes?
For us, more than the future we talk about the present. It is the therapeutic novelty today, with excellent results.
No one has to get used to living with pain, regardless of their injury or age.
Our advice is to seek different medical opinions and learn about all the possibilities that medicine offers us today.
In recent years science has evolved. It provides us with new treatments that allow us to treat and solve pathologies that were not possible a few years ago. This treatment with Monocytes adds a therapeutic alternative to those we already had and allows us to expand our range of therapies.
